Integer Holdings Corporation (NYSE:ITGR) Receives $98.38 Average PT from Analysts

Integer Holdings Corporation (NYSE:ITGR) has been given a consensus recommendation of “Hold” by the eleven brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $98.3750.

A number of equities research analysts have commented on ITGR shares. Bank of America cut shares of Integer from a “buy” rating to a “neutral” rating and set a $87.00 price target for the company. in a report on Friday, October 24th. Raymond James Financial restated an “outperform” rating and issued a $95.00 target price (down from $143.00) on shares of Integer in a research note on Friday, October 24th. Piper Sandler dropped their price target on Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Wells Fargo & Company reiterated an “equal weight” rating and issued a $80.00 price target (down previously from $132.00) on shares of Integer in a report on Friday, October 24th. Finally, Citigroup boosted their price objective on Integer from $69.00 to $75.00 and gave the company a “neutral” rating in a report on Thursday, December 11th.

Insider Buying and Selling at Integer

In related news, Director Cheryl C. Capps acquired 1,600 shares of the firm’s stock in a transaction on Thursday, November 6th. The stock was purchased at an average cost of $66.70 per share, with a total value of $106,720.00. Following the acquisition, the director owned 11,702 shares of the company’s stock, valued at approximately $780,523.40. This trade represents a 15.84% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Diron Smith acquired 1,116 shares of the stock in a transaction dated Friday, November 7th. The stock was bought at an average cost of $67.19 per share, with a total value of $74,984.04. Following the completion of the purchase, the executive vice president owned 7,698 shares of the company’s stock, valued at approximately $517,228.62. The trade was a 16.96% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders purchased 5,843 shares of company stock valued at $384,771. Insiders own 2.16% of the company’s stock.

Institutional Investors Weigh In On Integer

Several institutional investors have recently bought and sold shares of the stock. Salomon & Ludwin LLC purchased a new position in Integer during the 3rd quarter worth $26,000. Global Retirement Partners LLC lifted its position in shares of Integer by 293.8% during the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 238 shares in the last quarter. CWM LLC lifted its position in shares of Integer by 46.1% during the second quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 112 shares in the last quarter. MAI Capital Management boosted its holdings in Integer by 220.9% during the second quarter. MAI Capital Management now owns 369 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 254 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in Integer by 210.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after purchasing an additional 362 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Stock Up 2.5%

Shares of Integer stock opened at $82.91 on Tuesday. The stock’s 50-day moving average is $72.90 and its 200 day moving average is $94.80. Integer has a one year low of $62.00 and a one year high of $146.36. The firm has a market cap of $2.91 billion, a price-to-earnings ratio of 34.69, a PEG ratio of 0.74 and a beta of 0.78. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.The business’s revenue was up 8.4% compared to the same quarter last year. During the same period last year, the firm earned $1.43 EPS. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Equities research analysts anticipate that Integer will post 6.01 EPS for the current year.

Integer declared that its board has authorized a share repurchase plan on Tuesday, November 4th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the medical equipment provider to repurchase up to 8.3% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

Integer News Roundup

Here are the key news stories impacting Integer this week:

• Neutral Sentiment: Multiple plaintiff law firms have issued investor alerts reminding shareholders of the February 9, 2026 lead?plaintiff deadline and soliciting potential class members — this increases media attention and may concentrate filings but does not itself create a liability. Glancy Prongay & Murray LLP Notice
• Neutral Sentiment: Several firms (Rosen, Bernstein Liebhard, Berger Montague, Bragar Eagel & Squire, ClaimsFiler, etc.) are competing to represent the class — this is procedural and typical in high?profile equity declines; it can amplify headlines and short?term volatility. PR Newswire Notice
• Negative Sentiment: At least one class action asserts securities?fraud claims tied to Integer’s lowered sales outlook and a significant subsequent stock drop; allegations of prior misstatements or omissions increase the risk of settlement exposure, management distraction, and reputational damage. BFA Law Firm Filing/Alert
• Negative Sentiment: Other complaints claim undisclosed financial problems and link the firm’s ~32% stock decline to those issues — if proven, regulators or plaintiffs could seek significant damages; however, outcomes and liability amounts remain uncertain at this stage. Kahn Swick & Foti Notice
• Negative Sentiment: Practical investor impacts: (1) near?term volatility and downside pressure while litigation headlines persist, (2) potential for legal expenses and settlement accruals that could weigh on earnings or cash flow if claims advance, and (3) possible management time diverted to defense/settlement negotiations — all factors that can reduce valuation multiples until clarity emerges. Gross Law Firm Alert

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.